0001722024-20-000003.txt : 20200611 0001722024-20-000003.hdr.sgml : 20200611 20200611202429 ACCESSION NUMBER: 0001722024-20-000003 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200611 FILED AS OF DATE: 20200611 DATE AS OF CHANGE: 20200611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alexandria Venture Investments, LLC CENTRAL INDEX KEY: 0001722024 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39321 FILM NUMBER: 20958565 BUSINESS ADDRESS: STREET 1: 26 NORTH EUCLID AVENUE CITY: PASADENA STATE: CA ZIP: 91101 BUSINESS PHONE: 626-578-0777 MAIL ADDRESS: STREET 1: 26 NORTH EUCLID AVENUE CITY: PASADENA STATE: CA ZIP: 91101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avidity Biosciences, Inc. CENTRAL INDEX KEY: 0001599901 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461336960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10975 N. TORREY PINES RD., STREET 2: #150 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-401-7900 MAIL ADDRESS: STREET 1: 10975 N. TORREY PINES RD., STREET 2: #150 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Avidity Biosciences LLC DATE OF NAME CHANGE: 20161227 FORMER COMPANY: FORMER CONFORMED NAME: Avidity NanoMedicines LLC DATE OF NAME CHANGE: 20140211 3 1 wf-form3_159192144910391.xml FORM 3 X0206 3 2020-06-11 0 0001599901 Avidity Biosciences, Inc. RNA 0001722024 Alexandria Venture Investments, LLC 26 NORTH EUCLID AVENUE PASADENA CA 91101 0 0 1 0 Series A convertible preferred stock Common stock 187248.0 D Series B convertible preferred stock Common stock 251536.0 D Series C convertible preferred stock Common stock 63581.0 D The preferred stock is convertible into the Issuer's common stock at a ratio of 2.1095 shares of preferred stock to 1 share of common stock at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering, for no additional consideration. Not applicable. By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member By: /s/ Dean A. Shigenaga Chief Financial Officer 2020-06-11